Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument (SYMPHONYext)

This study has been terminated.
(Protocol-defined criterion of macitentan availability achieved.)
Information provided by (Responsible Party):
Actelion Identifier:
First received: May 2, 2013
Last updated: June 8, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2016
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)